Patent Foramen Ovale Clinical Trials

Find Patent Foramen Ovale Clinical Trials Near You

Establishment of Active Surveillance and Safety and Efficacy Evaluation Indicators for Innovative Devices Used in Interventional Treatment of Structural Heart Disease

Status: Recruiting
Location: See all (11) locations...
Study Type: Observational
SUMMARY

This study aims to establish an active surveillance system to evaluate the safety and effectiveness of innovative medical devices used in the interventional treatment of structural heart disease. The devices of interest include a biodegradable patent foramen ovale (PFO) closure device and a transcatheter mitral valve edge-to-edge repair system. Clinical information from patients receiving these devices during routine clinical care will be collected and analyzed. The findings will help evaluate the safety and effectiveness of these devices and support the development of appropriate clinical evaluation indicators and long-term monitoring strategies.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients undergoing implantation of a biodegradable PFO closure device.

• Patients undergoing transcatheter mitral valve edge-to-edge repair.

Locations
Other Locations
China
Beijing Anzhen Hospital, Capital Medical University
NOT_YET_RECRUITING
Beijing
FUWAI Hospital, CAMS&PUMC
NOT_YET_RECRUITING
Beijing
Sichuan Provincial People's Hospital
NOT_YET_RECRUITING
Chengdu
Guangdong Provincial People's Hospital
NOT_YET_RECRUITING
Guangzhou
Shandong Provincial Hospital
NOT_YET_RECRUITING
Jinan
Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences/Affiliated Cardiovascular Hospital of Kunming Medical University
NOT_YET_RECRUITING
Kunming
The First Hospital of Lanzhou University
RECRUITING
Lanzhou
East Hospital, Tongji University
NOT_YET_RECRUITING
Shanghai
General Hospital of Northern Theater Command, Chinese People's Liberation Army
NOT_YET_RECRUITING
Shenyang
Zhongnan Hospital of Wuhan University
RECRUITING
Wuhan
Fuwai Central China Cardiovascular Hospital
RECRUITING
Zhengzhou
Contact Information
Primary
Xinyi Xu
3342@scmc.com.cn
+86 18930830756
Backup
Kai Wang
30192@scmc.com.cn
+86 15317921903
Time Frame
Start Date: 2025-12-30
Estimated Completion Date: 2029-01-31
Participants
Target number of participants: 2200
Treatments
Biodegradable Patent Foramen Ovale Closure Device
Participants with patent foramen ovale (PFO) who receive a biodegradable PFO closure device as part of routine clinical care will be included in this cohort. Clinical data will be collected to evaluate the safety and effectiveness of the device during follow-up.
Transcatheter Mitral Valve Edge-to-Edge Repair System Cohort
Participants with degenerative or functional mitral regurgitation who undergo transcatheter mitral valve edge-to-edge repair using a transcatheter mitral valve edge-to-edge repair system. Safety and effectiveness outcomes will be assessed during follow-up.
Sponsors
Collaborators: Chinese Academy of Medical Sciences, Fuwai Hospital, Shandong Provincial Hospital, Beijing Anzhen Hospital, Sichuan Provincial People's Hospital, ScienTech Medical, LanZhou University, Guangdong Provincial People's Hospital, The General Hospital of Northern Theater Command, Zhongnan Hospital, Shanghai East Hospital of Tongji University, Valgen Medtech
Leads: Shanghai Jiao Tong University School of Medicine

This content was sourced from clinicaltrials.gov